Regulation of Blood Glycoproteins by Lectin Receptors in Health and Disease
健康和疾病中凝集素受体对血液糖蛋白的调节
基本信息
- 批准号:10658456
- 负责人:
- 金额:$ 48.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAllelesAlpha-mannosidaseAnimalsAutoimmune DiseasesBehavioralBindingBioinformaticsBloodBlood - brain barrier anatomyBlood Coagulation DisordersBlood ProteinsBlood VesselsBlood brain barrier dysfunctionBlood specimenBrainCardiovascular systemCell surfaceCellsChromatographyChronicChronic DiseaseClinicalCollaborationsDataData AnalysesDefectDegenerative DisorderDevelopmentDiseaseDisease MarkerDistalEnvironmental Risk FactorEukaryotaExoglycosidasesExperimental DesignsFucoseFunctional disorderGalactoseGlycoproteinsGlycoside HydrolasesGolgi ApparatusHealthHematologyHumanHydrolysisHypertensionIndividualInflammationInflammatoryInnate Immune SystemInvestigationLaboratoriesLaboratory miceLectinLectin ReceptorsLigandsLinkMammalsMannoseMannose Binding LectinMannosidaseMass Spectrum AnalysisMeasuresMeta-AnalysisMolecularMonitorMusNeurologicOnset of illnessOrganOutcomePathologicPathologyPeptidyl-Dipeptidase APeroxidasesPhenotypePhysiologicalPhysiologyPlasmaPlayPolymersPolysaccharidesPopulationPredispositionProcessProteinsProteomeProtocols documentationRegulationReninResearch ProposalsRoleSamplingSourceSterilityStructureSurfaceSyndromeSystemTissuesVascular Diseasesanomerautism spectrum disorderblood pressure elevationcell typecohorthealth determinantsinflammatory markerinhibitorlink proteinmannose receptorneuralpathogenproteostasisreceptor bindingvascular inflammation
项目摘要
SUMMARY
The composition of the blood proteome provides indications of normal health and the presence of disease.
Over 90% of non-albumin proteins in the blood of mammals are N-glycoproteins bearing N-glycan structures
produced in the Golgi apparatus prior to nascent glycoprotein secretion. We have previously discovered an
intrinsic mechanism controlling the half-lives and thereby abundance and function of circulating blood
glycoproteins. This mechanism is linked to the progressive glycosidic remodeling of nascent blood
glycoproteins by circulating exo-glycosidases thereby resulting in the exposure of cryptic endocytic lectin
receptor ligands. Endocytic lectin receptors are highly conserved among mammals and are expressed on the
surface of various vascular and organ cell types where they recognize and bind their ligands from among
circulating blood components and glycoproteins. We have found that this intrinsic mechanism of blood
glycoprotein remodeling and clearance by lectin receptors is targeted by pathogens and the resulting changes
in blood glycoprotein abundance are linked to disease onset. Lectin receptor ligands include glycosidic
linkages of galactose, N-acetylglucosamine, fucose, or mannose; however, glycoproteins bearing physiological
lectin receptor ligands remain mostly unknown and thus the functions of lectin receptors are also mysterious.
This laboratory has developed an approach to identify physiological blood glycoprotein ligands of individual
lectin receptors by chromatography and mass spectrometry protocols. A subset of mammalian lectin receptors
bind to glycosidic linkages bearing exposed mannose, herein termed mannosylated blood glycoproteins. This
laboratory discovered in past related studies that the accumulation of mannosylated glycoproteins due to
defects in N-glycan synthesis causes chronic inflammation, autoimmunity, and degenerative disease. Normally
however, the recognition and clearance of mannosylated blood glycoproteins involves the expression and
function of mannose binding lectins including Mrc1. This proposal addresses the hypothesis that Mrc1 controls
the levels of mannosylated blood glycoproteins in normal physiology and protects against the onset of disease.
Our supporting data demonstrate that Mrc1 has a blood ligand repertoire including key regulators of the
vasculature. Absence of Mrc1 results in the accumulation of mannosylated Renin and Angiotensin Converting
Enzyme with elevated blood pressure. In addition, accumulating mannosylated Myeloperoxidase in the blood is
associated with vascular inflammation, blood-brain barrier breakdown, tissue damage, and autism-like
features. The roles of Mrc1 ligands will be addressed with inhibitors. In the blood of humans, we have further
discovered a link between individuals with low levels of mannosidase activity and high levels of mannosylated
blood proteins. This proposal in summary will investigate how the accumulation of mannosylated blood
glycoprotein ligands in Mrc1 deficiency cause disease and establish whether humans bearing high levels of
mannosylated blood glycoproteins similarly contain elevated markers of inflammation and vascular defects.
概括
血液蛋白质组的组成提供了正常健康状况和疾病存在的指示。
哺乳动物血液中超过 90% 的非白蛋白是带有 N-聚糖结构的 N-糖蛋白
在新生糖蛋白分泌之前在高尔基体中产生。我们之前发现了一个
控制半衰期从而控制循环血液的丰度和功能的内在机制
糖蛋白。这种机制与新生血液的渐进糖苷重塑有关
通过循环外切糖苷酶分解糖蛋白,从而导致隐藏的内吞凝集素的暴露
受体配体。内吞凝集素受体在哺乳动物中高度保守,并表达于
各种血管和器官细胞类型的表面,它们识别并结合其中的配体
循环血液成分和糖蛋白。我们发现血液的这种内在机制
凝集素受体的糖蛋白重塑和清除是病原体的目标,以及由此产生的变化
血液中糖蛋白的丰度与疾病的发生有关。凝集素受体配体包括糖苷
半乳糖、N-乙酰氨基葡萄糖、岩藻糖或甘露糖的键;然而,糖蛋白具有生理作用
凝集素受体配体大多仍是未知的,因此凝集素受体的功能也是神秘的。
该实验室开发了一种识别个体生理血糖蛋白配体的方法
通过色谱法和质谱法检测凝集素受体。哺乳动物凝集素受体的一个子集
结合带有暴露的甘露糖的糖苷键,本文称为甘露糖化血糖蛋白。这
实验室在过去的相关研究中发现,甘露糖蛋白的积累是由于
N-聚糖合成缺陷会导致慢性炎症、自身免疫和退行性疾病。通常情况下
然而,甘露糖化血糖蛋白的识别和清除涉及表达和
甘露糖结合凝集素(包括 Mrc1)的功能。该提案解决了 Mrc1 控制的假设
正常生理中甘露糖化血液糖蛋白的水平,并预防疾病的发作。
我们的支持数据表明 Mrc1 具有血液配体库,包括血液配体的关键调节因子
脉管系统。 Mrc1 的缺失会导致甘露糖化肾素和血管紧张素转换的积累
酶与血压升高。此外,血液中积累的甘露糖化髓过氧化物酶
与血管炎症、血脑屏障破坏、组织损伤和自闭症样症状有关
特征。 Mrc1 配体的作用将通过抑制剂来解决。在人类的血液中,我们还有
发现甘露糖苷酶活性水平低的个体与甘露糖苷化水平高的个体之间存在联系
血液蛋白质。总而言之,该提案将研究甘露糖化血液的积累如何
Mrc1 缺陷中的糖蛋白配体会导致疾病,并确定人类是否携带高水平的
甘露糖化血糖蛋白同样含有升高的炎症和血管缺陷标记物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMEY MARTH其他文献
JAMEY MARTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMEY MARTH', 18)}}的其他基金
Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease
细胞表面糖蛋白稳态和疾病中的蛋白质唾液酸化和去唾液酸化
- 批准号:
10211776 - 财政年份:2021
- 资助金额:
$ 48.75万 - 项目类别:
Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and Disease
细胞表面糖蛋白稳态和疾病中的蛋白质唾液酸化和去唾液酸化
- 批准号:
10552654 - 财政年份:2021
- 资助金额:
$ 48.75万 - 项目类别:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
脓毒症凝血障碍和炎症中的蛋白质糖基化
- 批准号:
10475586 - 财政年份:2016
- 资助金额:
$ 48.75万 - 项目类别:
PROJECT 1 - Host Neuraminidases in Hemostasis and Sepsis
项目 1 - 宿主神经氨酸酶在止血和脓毒症中的作用
- 批准号:
10171428 - 财政年份:2016
- 资助金额:
$ 48.75万 - 项目类别:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
脓毒症凝血障碍和炎症中的蛋白质糖基化
- 批准号:
10641837 - 财政年份:2016
- 资助金额:
$ 48.75万 - 项目类别:
Protein Glycosylation in the Coagulopathy and Inflammation of Sepsis
脓毒症凝血障碍和炎症中的蛋白质糖基化
- 批准号:
9916805 - 财政年份:2016
- 资助金额:
$ 48.75万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 48.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




